INTRODUCTION
============

Age-related macular degeneration (ARMD) is one of the top four causes of blindness in elderly people. ARMD, described more than 80 years ago, is a progressive disease of the central area in the ocular posterior segment (the macula lutea), which leads to a gradual deterioration in central vision and causes severe disability to affected individuals. In North America, Europe, and Australia, ARMD accounts for up to half of all cases of central blindness, affecting approximately 3% of the general adult population. In the United States, about 12%--15% of people older than 80 years of age were estimated to have ARMD in 2000, and this number is expected to be more than 2.95 million in 2020. People with ARMD have been found to experience reduced quality of life, depression, and difficulty with the activities of daily living, which pose serious financial burden on their family in terms of high medical and societal costs that are due to increased risk of falling, need for vision enhancing equipment, depression/anxiety treatment, and assistance with activities of daily living ([@B1], [@B2]).

Visual loss in late ARMD can be caused by either of the following two processes that cause photoreceptor dysfunction: geographic atrophy (GA) or choroidal neovascularization. GA refers to the confluent atrophy of the choriocapillaris and associated retinal pigment epithelium (RPE). The RPE is the outermost layer of the retina, which is involved in phagocytosis of the photoreceptor outer segments and biologic maintenance. In choroidal neovascularization, an ingrowth of new vessels occurs from the choriocapillaris invading the retina. These new vessels leak serous fluids beneath and into the neural retina causing fibrous scarring, which defines the late stage of ARMD (exudative, or neovascular) ([@B3]). Non-exudative (dry) ARMD is often marked by the formation of drusen, pigmentary changes in the RPE, and atrophy of the RPE. Dry ARMD is more common; in one series of autopsy eyes, ARMD was found in 33% of patients older than 65 years ([@B4], [@B5]).

The incidence of the disease increases with age. Through major breakthrough discoveries made in the last decade in treating the wet form of ARMD, the chance of stabilizing or increasing vision has been increased to 90%. Nonetheless, this improvement is associated with a significant price tag of monthly intravitreal injections (with the ever-present phantom of endophthalmitis and other injection-related adverse events) and uncertainty regarding the duration of treatment ([@B6]).

A scientometrics method is one that measures and analyzes scientific publications related to a specific topic regarding the trends in citations, most important content, authors, and journals. A widespread use of scientometric method goes back to 1960s when Eugene Garfield finalized the construction of Science ([@B7]). In this article, we performed the first scientometric analysis of the ARMD field to elucidate the most important trends and directions of this subject.

MATERIAL AND METHODS
====================

A bibliometric study was performed on the articles related to "Age-Related Macular Degeneration" published between 1993 and 2013. The Institute for Scientific Information (ISI) web of science available at http://www.isiknowledge.com was our main source. Two mesh terms---"Age-Related Macular Degeneration" and "ARMD"---already checked in Pubmed mesh database were used to conduct the search.

Only original articles were selected for further evaluation. These articles were evaluated regarding citation characteristics, contributing role of each author, country, funding agency, institution, journal, and language of published articles. Articles were also evaluated regarding the trend of publication and citation during a selected time and also subject areas covered. Articles that were published in 10 countries with the greatest number of publications on the topic were analyzed separately.

Articles published by each country were evaluated regarding subject areas and publishing journals. Special attention was paid to total citations with and without self-citation, citation per year, and citation per item for journals of each country. Articles that were cited more than 100 times were evaluated regarding year of publication, country of affiliation of the first author, and publishing journal. Number, country, and year of collaborative studies were also considered. All three resources available in the ISI web of science were used for this purpose (Science Citation Index Expanded, Social Sciences Citation Index, The Arts & Humanities Citation Index). For the citation analysis, two parameters were calculated: Local Citation Score (LCS) and Global Citation Score (GCS). LCS listed all papers sorted by citation frequency within the local (the starting bibliography) collection; however, GCS counted citations in the whole collection. For the citation burst analysis, first, 100 key words that generated the citation bursts were extracted, and then non-specific and general key words were omitted.

RESULTS
=======

*Annual Publication Number During 1993-2013*

A total of 3235 research articles were available on ARMD in the ISI Web of Science during 1993-2013. These papers were drafted by 10,706 authors, 2332 institutions, and 67 countries and were published in 388 journals in 9 languages. [Figure 1](#F1){ref-type="fig"} demonstrates the growth rate of publications in this field (14.46% per year). The H-index of this subject was 125.

*Citation Profile of Articles*

The total LCS citations were 29,924 in number and GCS citations were 91,840 in number. The average citation per paper (C/P) was 28.39

[Table 1](#T1){ref-type="table"} shows the articles that were cited 100 or more times. [Figure 2](#F2){ref-type="fig"} shows the trend of citations during the period. Appendix 1 shows the highly cited articles in this field. [Figure 1](#F1){ref-type="fig"} shows the histogram map of 20 years of research in this field.

[Figure 3](#F3){ref-type="fig"} shows the key words generating the highest citation bursts and the time periods associated with them. The key words associated with the highest citation bursts included: drusen, choroidal neovascular membranes, subfoveal neovascular membranes, neovascularization, subretinal neovascularization, blindness, fluorescein angiography, retinal pigment epithelium, choroidal perfusion abnormality, indocyanine green angiography, dystrophy, Beaver dam eye, Bruch membrane change, angiography, neovascular membranes, radiation therapy, photocoagulation, videoangiography, indocyanine green videoangiography, occult choroidal neovascularization, choriocapillaris, teletherapy, retinitis pigmentosa, Stargardt disease, mutations, apolipoprotein E, subfoveal choroidal neovascularization, laser photocoagulation, genome-wide scan, susceptibility loci, verteporfin therapy, c-reactive protein, avastin, pegaptanib, ranibizumab, polypoidal choroidal vasculopathy, complement factor H, bevacizumab, optical coherence tomography, polymorphism, endothelial growth factor, and vascular endothelial growth factor.

*Subject Analysis of the Most Highly Cited Documents*

The most common topics of the top 10 highly cited papers were genetic epidemiology research (40%), clinical study (surgical or pharmaceutical treatment) (50%), and epidemiologic study (10%) ([Table 1](#T1){ref-type="table"}). *Languages, Journal Subjects, and Author Profiles of Publications*

Most ARMD articles were in English (3068), followed by German (105) and French (47). In total, the articles were written in nine languages (English, German, French, Portuguese, Hungarian, Spanish, Polish, Serbian, and Slovene). Dr R. Klein, with 80 articles, had the largest number of publications in the field of ARMD research ([Table 2](#T2){ref-type="table"}). When analyzed based on the number of papers in ARMD, 8 out of top 10 journals were general medical journals (such as the New England Journal of Medicine) and the remaining were ophthalmology journals. But when the same calculation was made based on the citation number (TLCS), seven journals were general medical journals and three were ophthalmology journals. When analyzed based on TGCS, highly cited papers were mostly published in general medical journals (80%), and the remaining 20% were published in Ophthalmology journals ([Tables 3](#T3){ref-type="table"}). No correlation was found between the impact factor of the most highly influential journals in this field and the total citations they had received for their papers in the field of ARMD.

A majority of the top 10 universities and institutions in the list are from the United States and Australia. The first two of them are the Johns Hopkins University and University of Melbourne in terms of number of documents and Harvard University and University of Wisconsin in terms of number of citations ([Table 4](#T4){ref-type="table"}).

*Geographical Distribution*

In general, 67 countries contributed to the promotion of the field of ARMD by publishing articles. The United States, Germany, and the UK had the highest number of documents but they had the highest number of citations to their research papers in the field of ARMD ([Table 5](#T5){ref-type="table"}).

###### 

Articles With Highest Number of Citations

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **\#**   **Author/ Title / Journal**                                                                                                                                                                                  **CITATION**
  -------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -- --------------
  **1**    Klein Rj, Zeiss C, Chew Ey, Tsai Jy, Sackler Rs, Et Al.\                                                                                                                                                     1814
           Complement Factor H Polymorphism In Age-Related Macular Degeneration\                                                                                                                                        
           Science. 2005 Apr 15; 308 (5720): 385-389                                                                                                                                                                    

  **2**    Rosenfeld Pj, Brown Dm, Heier Js, Boyer Ds, Kaiser Pk, Et Al.\                                                                                                                                               1662
           Ranibizumab For Neovascular Age-Related Macular Degeneration\                                                                                                                                                
           New England Journal Of Medicine. 2006 Oct 5; 355 (14): 1419-1431                                                                                                                                             

  **3**    Edwards Ao, Ritter R, Abel Kj, Manning A, Panhuysen C, Et Al.\                                                                                                                                               1173
           Complement Factor H Polymorphism And Age-Related Macular Degeneration\                                                                                                                                       
           Science. 2005 Apr 15; 308 (5720): 421-424                                                                                                                                                                    

  **4**    Brown Dm, Kaiser Pk, Michels M, Soubrane G, Heier Js, Et Al.\                                                                                                                                                1161
           Ranibizumab Versus Verteporfin For Neovascular Age-Related Macular Degeneration\                                                                                                                             
           New England Journal Of Medicine. 2006 Oct 5; 355 (14): 1432-1444                                                                                                                                             

  **5**    Haines Jl, Hauser Ma, Schmidt S, Scott Wk, Olson Lm, Et Al.\                                                                                                                                                 1148
           Complement Factor H Variant Increases The Risk Of Age-Related Macular Degeneration\                                                                                                                          
           Science. 2005 Apr 15; 308 (5720): 419-421                                                                                                                                                                    

  **6**    Gragoudas Es, Adamis Ap, Cunningham Et, Feinsod M, Guyer Dr\                                                                                                                                                 1146
           Pegaptanib For Neovascular Age-Related Macular Degeneration\                                                                                                                                                 
           New England Journal Of Medicine. 2004 Dec 30; 351 (27): 2805-2816                                                                                                                                            

  **7**    Kassoff A, Kassoff J, Buehler J, Eglow M, Kaufman F, Et Al.\                                                                                                                                                 1081
           A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation With Vitamins C And E, Beta Carotene, And Zinc For Age-Related Macular Degeneration And Vision Loss - Areds Report No. 8\      
           Archives Of Ophthalmology. 2001 Oct; 119 (10): 1417-1436                                                                                                                                                     

  **8**    Bressler Nm\                                                                                                                                                                                                 1021
           Photodynamic Therapy Of Subfoveal Choroidal Neovascularization In Age-Related Macular Degeneration With Verteporfin - One-Year Results Of 2 Randomized Clinical Trials - Tap Report 1\                       
           Archives Of Ophthalmology. 1999 Oct; 117 (10): 1329-1345                                                                                                                                                     

  **9**    Friedman Ds, O\'colmain B, Tomany Sc, Mccarty C, De Jong Ptvm, Et Al.\                                                                                                                                       970
           Prevalence Of Age-Related Macular Degeneration In The United States\                                                                                                                                         
           Archives Of Ophthalmology. 2004 Apr; 122 (4): 564-572                                                                                                                                                        

  **10**   Hageman Gs, Anderson Dh, Johnson Lv, Hancox Ls, Taiber Aj, Et Al.\                                                                                                                                           929
           A Common Haplotype In The Complement Regulatory Gene Factor H (Hf1/Cfh) Predisposes Individuals To Age-Related Macular Degeneration\                                                                         
           Proceedings Of The National Academy Of Sciences Of The United States Of America. 2005 May 17; 102 (20): 7227-7232                                                                                            
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Most Active Authors in the Field of ARMD Research

  **\#**   **Author**          **Recs**   **TLCS**   **TGCS**
  -------- ------------------- ---------- ---------- ----------
  **1**    Klein R             80         2405       6370
  **2**    Bressler Nm         76         3639       10146
  **3**    Mitchell P          63         1300       3350
  **4**    Soubrane G          60         1202       3152
  **5**    Seddon Jm           58         2269       6377
  **6**    Schmidt-Erfurth U   56         1511       4504
  **7**    Holz Fg             55         550        2187
  **8**    Guymer Rh           52         310        855
  **9**    Wong Ty             52         422        1004
  **10**   Bressler Sb         48         2546       6735
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###### 

Journals with Highest Number of Papers in This Field

  **\#**   **Journal**                                                          **Records**   **Citation**   **2 year IF**   **5 year IF**
  -------- -------------------------------------------------------------------- ------------- -------------- --------------- ---------------
  **1**    Ophthalmology                                                        289           12624          5.563           5.777
  **2**    Investigative Ophthalmology & Visual Science                         274           7421           3.441           3.730
  **3**    American Journal Of Ophthalmology                                    232           8043           3.631           4.292
  **4**    Retina-The Journal Of Retinal And Vitreous Diseases                  225           3933           2.825           2.761
  **5**    British Journal Of Ophthalmology                                     198           4462           2.725           3.023
  **6**    Archives Of Ophthalmology                                            166           13369          3.826           4.160
  **7**    Graefes Archive For Clinical And Experimental Ophthalmology          125           2550           1.932           2.037
  **8**    Eye                                                                  97            1015           1.818           1.883
  **9**    Molecular Vision                                                     73            1210           1.987           2.311
  **10**   Acta Ophthalmologica                                                 65            408            2.345           2.428
  **11**   Ophthalmologica                                                      57            503            1.412           1.236
  **12**   Klinische Monatsblatter Fur Augenheilkunde                           49            197            0.699           0.473
  **13**   Ophthalmologe                                                        48            295            0.529           0.681
  **14**   European Journal Of Ophthalmology                                    46            296            0.912           0.963
  **15**   Journal Francais D Ophtalmologie                                     45            112            0.438           0.443
  **16**   Japanese Journal Of Ophthalmology                                    43            234            1.274           1.488
  **17**   PLose One                                                            43            493            3.730           4.244
  **18**   Ophthalmic Surgery Lasers & Imaging                                  39            634            1.464           0.922
  **19**   Canadian Journal Of Ophthalmology-Journal Canadien D Ophtalmologie   38            398            1.145           1.320
  **20**   Clinical And Experimental Ophthalmology                              28            291            1.964           2.047

###### 

Institutions with Highest Number of Papers

  \#       **Institution**       **Records**   **Citations**
  -------- --------------------- ------------- ---------------
  **1**    Johns Hopkins Univ    130           7472
  **2**    Univ Melbourne        125           3103
  **3**    Harvard Univ          117           9211
  **4**    Duke Univ             97            4450
  **5**    Univ Wisconsin        97            6462
  **6**    Nei                   86            6282
  **7**    Univ Sydney           79            3584
  **8**    Moorfields Eye Hosp   73            2029
  **9**    Univ Penn             73            3241
  **10**   Univ Southern Calif   68            1737
  **11**   Univ Heidelberg       64            1960
  **12**   Univ Miami            57            5242
  **13**   UCL                   54            1273
  **14**   Univ Paris 12         53            2140
  **15**   Natl Univ Singapore   51            809
  **16**   Univ Cologne          50            1054
  **17**   Univ Utah             49            2540
  **19**   Univ Iowa             48            3215
  **20**   Univ Bonn             47            1190

Discussion
==========

We analyzed the subject of highly cited papers, dividing them into two broad categories: epidemiology versus clinical research and translational versus basic science research (Appendix 1). Most of the highly cited papers were genetic epidemiology or clinical reports. Although ARMD is a debilitating disease and adversely affects the quality of life and emotional status of subjects, highly cited papers had largely neglected this subject. Highly cited reports also addressed the following subjects more frequently: (1) association of various genotypes with ARMD, (2) chemotherapy for wet ARMD, including the intravitreal treatment, and (3) effect of diet and vitamins on ARMD. Recently, as Appendix 2 shows, there has been a trend toward more applicable genetic epidemiology and translational research (biomarkers). In cluster analysis for the citations, we found the following three major clusters in the citation histogram map ([Figure 1](#F1){ref-type="fig"}): (1) complement H factor polymorphism in the ARMD (nodes 831, 832, 833, and 842 in the index 1), (2) treatment of subfoveal choroidal neovascularization in ARMD (nodes 386, 402, and 428), and (3) ranibizumab treatment for neovascular ARMD (nodes 1116 and 1117).

###### 

Countries With Highest Number of Papers in the Field of ARMD

  **\#**   **Country**       **Recs**   **CITATION**
  -------- ----------------- ---------- --------------
  **1**    USA               1338       60915
  **2**    Germany           363        8968
  **3**    UK                340        9990
  **4**    Australia         215        6031
  **5**    Japan             193        3740
  **6**    France            163        4862
  **7**    Peoples R China   144        2486
  **8**    Italy             120        1842
  **9**    Austria           112        3371
  **10**   Unknown           105        2707
  **11**   Canada            97         3205
  **12**   Switzerland       92         2959
  **13**   Netherlands       74         4699
  **14**   Spain             65         1184
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Proportionally, articles related to medical retina compared to other subspecialties have increased between 2005 and 2009. In an analytical study of the ophthalmology research papers, case--control or cohort studies comprised most study designs used (40.1%), followed by non-analytic studies (28.7%), basic science (24.6%), RCTs (3.3%), review articles (2.6%), and meta-analyses (0.3%) ([@B8]). However, the trend was not similar in the ARMD research for the highly cited papers. As Graph 3 shows, in the 1990s, the key words that resulted in the most strong citation bursts were the ones associated with pathophysiology, such as subretinal neovascularization; however, in the past 4 years, there has been a trend toward novel treatments such as ranibizumab in the context of RCTs, which shows the importance of this line of research and also the progression in the field of ARMD. Both the citation burst analysis and the histography of the most cited papers in the past 3 years showed that genetic epidemiology topics are among the recent hot topics in this field. Interestingly, genetic epidemiology studies also comprised the most highly cited articles in the past 20 years, which implies that this field is still hot and many more studies have a high chance of publication in this field.In our study, the number of citations correlated poorly with the impact factor of the journals. Citation frequency and impact factor both render important information regarding the merit of a paper, but the ranking of research groups on the basis of journal impact factor is shown to have little correlation with the ranking of the same groups on the basis of citation frequency. This can be due to the fact that journals with an advance online publication had higher impact factors compared with those without an advance online publication. Also, researchers might prefer to publish their results in their subspecialty journal, which might not necessarily have a high impact factor. It is suggested that "citation analysis is a good rough indicator of the quality of work as it is perceived by other scientists" ([@B9]). Previously, two detailed citation analysis reports have been published, one spanning the period of 1850--1949 ([@B10]) and the other 1975--2006 ([@B11]). In both reports, ARMD was a major citation classic, especially for ophthalmology journals. The second report surveyed 46 ophthalmology journals and concluded that the 100 most cited articles were published in 13 journals, including the Archives of Ophthalmology, Ophthalmology, and the American Journal of Ophthalmology ([@B11]). Epidemiology of ARMD was one of the major topics of 100 most cited articles. Also we found that the H-index of ARMD was 125, which indicates the appreciation of the context of ARMD within vision research. The publications of Dr Klein and several other top researchers in the field of ARMD research are also among the top 100 most cited articles in the field of Ophthalmology, which shows the importance of this field.
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Several lines of research have been previously identified as priorities in ARMD research. These include temporal patterns and changing the prevalence of ARMD; improvements of ocular imaging (eg, high-resolution OCT) to allow better phenotype classification of both early and late ARMD; and epidemiologic studies to determine gene-environment interactions for ARMD to identify early modifiable risk factors to prevent ARMD ([@B12]). According to the results of our study, several of these areas do not receive enough attention from the experts in the field, and better research strategies should be implemented.

In conclusion, the result of our report as the first scientometric analysis of the research on ARMD can be used as a guideline for authors, researchers, and policy makers to determine the best ways to allocate their financial and workforce resources.
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